|
Patient: 21 year old female![]() |
History: 21 year-old woman with severe post-partum cardiomyopathy � What device has been placed? � Figure 1 Figure 2 � The�device was placed approximately 1 year and 9 months ago and there is now purulent discharge at the drive-line skin entrance site.� What study would you like to perform next? � Figure 3 Figure 4 � Findings and their significance? � Next�step in management?� |
Image Size:![]() ![]() ![]()
![]() ![]() ![]() |
Findings: Limited Leukocyte Scintigraphy � RADIOPHARMACEUTICAL: 0.46 mCi In-111 labeled autologous leukocytes i.v. � Focus of increased tracer uptake in the superficial anterior right mid abdomen� � Microbiology (drive Line) � Rare gram positive cocci � Follow Up � The patient was subsequently treated with an LVAD drive line exit site revision |
DDx: Leukocyte scintigraphy evaluates the extent of drive-line and device involvement. � Exit site only � Exit site and drive-line � Exit site, drive-line, and device |
Diagnosis: Left Ventricular Assist Device (LVAD) drive line infection, relatively superficial�in location�at the skin entrance site. � |
References: Pasque et al. "Surgical Management of Novacor Drive-Line Exit Site Infections" Ann Thorac Surg. 2002; 74:1267-1268. |
Comments: ![]() No comments posted. |
Additional Details:
Case Number: 245518 The reader is fully responsible for confirming the accuracy of this content. |